This Stock Soared 123%: Is It Still a Buy for 2026?
A fast IPO run can leave investors excited but unsure what comes next. We break down whether this stock soared 123% s...
This article explains disallowed losses under crypto wash sale rules for 2026 and what it means for your tax planning and recordkeeping.
20,013 articlesA fast IPO run can leave investors excited but unsure what comes next. We break down whether this stock soared 123% s...
Tesla posts stronger margins amid a delivery dip, while Rivian turns profitable on software and a hopeful R2 ramp. An...
Magnolia (MGY) is delivering a pivotal Q1 2026 performance that tests the durability of its business model. This arti...
Cognex is navigating a world of AI-powered machine vision in manufacturing. This article breaks down the Q1 2026 resu...
Halozyme’s halo (HALO) 2026 earnings landscape hinges on ENHANZE collaborations, pipeline milestones, and disciplined...
DraftKings fights for growth across shifting state rules and expanding iGaming. This article breaks down what to watc...
Get a clear read on Deft's Q1 2026 results, margins, and guidance. This analysis shows what the deft 2026 earnings tr...
A practical, investor-focused look at Kestra Medical's (KMTS) 2026 earnings trajectory. We unpack expected revenue dr...
2026 could be a pivotal year for NVIDIA as AI demand reshapes its earnings trajectory. This guide breaks down the dri...
Step into the 2026 beauty health (skin) investing landscape. This guide translates early 2026 earnings signals into a...
Archer’s Q1 2026 numbers set the tone for the year. This article breaks down the earnings call, explains what really ...
Investors eyeing mdxhealth (mdxh) 2026 earnings will focus on adoption rates, reimbursement, and partnerships. This g...